Science1 distinct publisher3 min readPublished
A physician's post-Dobbs forecasts scored one hit out of four: infant mortality up 5.6% in restrictive states, while maternal deaths, abortion counts and OB-GYN flight refused to cooperate.
The Scientist · Science desk
Compiled by The ScientistSomething wrong?How this is made
Score the forecasts and one lands cleanly. The physician writing in STAT reports a relative increase of 5.6% in infant mortality in heavily restricted states, citing one study [3]. The other three predictions he held in 2022 do not appear in the aggregate data [1].
The asymmetry is not mysterious. Infant deaths in this setting sit at the end of a short causal chain: states banned abortion for congenital or genetic anomalies including those incompatible with survival, so more infants are born with those conditions and more die, and patients with high-risk conditions are being carried to term [4]. Maternal deaths are rarer events measured against a noisier background. The bans arrived alongside the tail of Covid-19 mortality, which complicates any attempt to separate overlapping effects [6]. Ban states already had worse maternal mortality before Dobbs, and those gaps have on average held steady since [7]. A null result assembled from those ingredients is not evidence that nothing happened, which is roughly the author's point when he notes that a stable national figure can conceal deterioration inside restrictive states or among minoritized groups [8], and that patients have died as direct results of bans regardless of what the national line does [9].
The abortion count is the more interesting failure, because the reason it failed is itself the story. Law is one input among economics, contraception and social change [12], and the legal change was met by activists, advocates and clinicians working to preserve access, often through telehealth and sometimes at personal legal risk [13]. The national number, in other words, is partly a measurement of the countermeasure rather than of the restriction. That also tells you how durable it is: much of the preserved access depends on mifepristone, which faces legal peril [14]. A count held up by one drug has one place to break. And national averages say nothing about the people in restrictive states who still are not reaching care [15].
On physicians, the estimates the author cites put net movement of OB-GYNs from restrictive to unrestrictive places at zero, or 1% to 2% [16]. Net is a difference between two flows, and he is careful to separate the individual doctors who did relocate from the nationwide exodus that was expected and did not arrive [17].
What the piece does with all this is refuse the obvious trade. The author's conclusion is that the failure of the worst predictions is not a reason for anyone to revise their view of abortion restrictions, if the guiding principles are autonomy and freedom [18]. He adds that in the country with the worst maternal and pregnancy-associated mortality among high income nations [10], an unchanged rate is a tragedy and not a case for celebrating stability [19]. That is a bill coming due for outcome-based advocacy on both sides. Arguments staked on forecasts inherit whatever the data eventually say, and four years is long enough for some of it to arrive [2].
Ranked by verification strength, evidence, and original report placement.
The author, a physician writing in STAT, assumed after Roe v. Wade was overturned that abortion rates would fall, that infant and maternal deaths would both worsen, and that doctors in heavily restricted states would leave for other parts of the country.
More than four years after the Supreme Court decision in Dobbs v. Jackson Women's Health Organization, an emerging picture is available and many outcomes are surprising.
Two likely reasons for higher infant mortality: numerous states banned abortion for any congenital or genetic anomaly, including those inconsistent with survival, so more babies are born with these conditions and die; and patients with high-risk conditions are forced to continue pregnancies, often with adverse outcomes.
The bans coincided with the tail of the Covid-19 pandemic, and because the virus alone drove mortality, attempts to measure overlapping effects are complicated.
A stable overall mortality figure can mask worse outcomes in restrictive states or within minoritized groups.
Since Dobbs, individual patients have died as direct results of bans.
Follow any of these and your For You feed starts watching them — no settings page required.
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
Single opinion column citing unnamed studies
The cluster contains exactly one source, a signed opinion piece by a maternal-fetal medicine specialist. Its central quantitative claims — a 5.6% relative rise in infant mortality and zero to 1%-2% net OB-GYN migration — are attributed to 'one study' and 'recent estimates' with no journal, author, dataset, or date, and no primary document is supplied for verification. Non-quantitative claims about the author's own reasoning and normative position are fully supported by the text; the empirical spine is not.
No adoption or deployment events in cluster
This is a health-policy outcomes analysis, not a technology or product story. The supplied source records no releases, deployments, benchmarks, pricing or licence changes, or disclosed usage figures, and the one delivery-channel mention (telehealth-based access) carries no volumes, provider counts, or dates. No adoption observation can be constructed without inventing facts.
Scorecard framing outruns its unnamed sources
The story framing — 'one prediction in four survived contact with the numbers' — is a crisp verdict resting on figures the source never identifies, and the author's own closing caveat is that mortality and workforce effects may simply be delayed rather than circumvented. The overstatement is modest rather than severe: the piece is explicitly hedged, volunteers its confounders, and refuses to convert null results into a policy conclusion, so the gap comes from precision claimed on unverifiable numbers rather than from inflated conclusions.
Advocacy op-ed with disclosed book promotion
The byline identifies the author as a professor of reproductive biology and division chief of maternal fetal medicine promoting a newly published book, and the column closes with an explicit advocacy stance ('we should be fighting for freedoms') plus an argument that adverse data are unnecessary to justify opposition. Those incentives are visible on the page and shape claim selection and hedging; they are disclosed rather than hidden, which moderates the score.
Directionally credible, quantitatively unverified
Confidence is limited by single-source, single-publisher coverage and by uncited statistics, but is not minimal: the author is a domain specialist, the column self-reports against his own prior predictions, and it discloses the confounders and masking effects that would undercut its own conclusions. Enough to treat the direction of travel as plausible; not enough to rely on any specific number.
science
Text watermarks land on 2 December. The detection they imply does not.1 distinct publisher
science
A vaccine communicator's testable claim: hesitancy answers to burden, not to better facts1 distinct publisher
science
Stewardship is aimed at the wrong half: rich countries use the resistance drugs, LMICs need them1 distinct publisher
science
A cancer charity sunsets its liquor gala; the courts are less consistent1 distinct publisher
Distinct publishers with included, body-backed reporting in this cluster.